Skip to main navigation Skip to search Skip to main content

Flecainide toxicity late after liver transplantation

Research output: Contribution to journal › Article › peer-review

Abstract

Flecainide is an antiarrhythmic agent indicated for patients with supraventricular arrhythmias without ischemic or structural heart disease. Flecainide toxicity is a rare condition in which patients may present with bradycardia, widening of QRS, PR prolongation, ventricular tachycardia, syncope, malaise, dizziness, visual disturbance, nausea, vomiting, and/or lethargy. It carries an associated mortality rate of approximately 10%. Herein, we describe the course of a patient who experienced flecainide toxicity in the setting of renal and liver failure.

Original languageEnglish (US)
Pages (from-to)378-379
Number of pages2
JournalBaylor University Medical Center Proceedings
Volume34
Issue number3
DOIs
StatePublished - 2021
Externally publishedYes

Keywords

  • Antiarrhythmic
  • flecainide
  • supraventricular tachycardia

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Flecainide toxicity late after liver transplantation'. Together they form a unique fingerprint.

Cite this